Video

The Challenge of High Cost Drugs in Specialty Pharmacy

Author(s):

Davy James, Managing Editor

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Gang | stock.adobe.com
Related Content
High-density lipoprotein particles(HDL) also known as good cholesterol, in the blood. Higher HDL levels correlate with lower risk of cardiovascular disease
August 24th 2025

Elevated High-Density Lipoprotein Cholesterol May Reduce Risk of Stress Urinary Incontinence

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
August 24th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Diagnosis papers for chronic kidney disease (CKD) -- Image credit: Dzmitry | stock.adobe.com
August 24th 2025

UNI-494 Receives US Patent for Treatment of Chronic Kidney Disease

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
August 24th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Bleeding stroke brain artery, Cellular structure with intricate connections and a vibrant red nucleus, representing biological elements.
August 24th 2025

Atorvastatin Improves Outcomes, LDL-C Following Pipeline Therapy for Intracranial Aneurysms

Luke Halpern, Assistant Editor
Treatment for chronic kidney disease (CKD) -- Image credit: jarun011 | stock.adobe.com
August 24th 2025

Study Finds Biomarkers That May Help Predict, Manage Chronic Kidney Disease

Gillian McGovern, Associate Editor